PCAS SA

ENXTPA:PCA Stock Report

Market Cap: €109.9m

PCAS Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for PCAS.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth26.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Statutory Earnings May Not Be The Best Way To Understand PCAS' (EPA:PCA) True Position

Sep 14
Statutory Earnings May Not Be The Best Way To Understand PCAS' (EPA:PCA) True Position

Is PCAS (EPA:PCA) A Risky Investment?

Dec 19
Is PCAS (EPA:PCA) A Risky Investment?

Is PCAS (EPA:PCA) Weighed On By Its Debt Load?

May 24
Is PCAS (EPA:PCA) Weighed On By Its Debt Load?

Did You Miss PCAS' (EPA:PCA) 48% Share Price Gain?

Mar 02
Did You Miss PCAS' (EPA:PCA) 48% Share Price Gain?

PCAS'(EPA:PCA) Share Price Is Down 48% Over The Past Three Years.

Nov 25
PCAS'(EPA:PCA) Share Price Is Down 48% Over The Past Three Years.

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PCAS has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ENXTPA:PCA - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20232309-44-3N/A
3/31/2023228-20-48-11N/A
12/31/2022226-49-53-18N/A
9/30/2022208-58-58-27N/A
6/30/2022191-67-64-36N/A
3/31/2022189-54-50-20N/A
12/31/2021187-40-36-5N/A
9/30/2021191-27-34-3N/A
6/30/2021195-14-32-1N/A
3/31/2021195-15-33-2N/A
12/31/2020194-15-34-3N/A
9/30/2020199-13-33-2N/A
6/30/2020204-11-330N/A
3/31/2020202-12-305N/A
12/31/2019201-14-269N/A
9/30/2019205-9N/AN/AN/A
6/30/2019209-6-433N/A
3/31/2019208-3-231N/A
12/31/20182070030N/A
9/30/2018208-1N/AN/AN/A
6/30/20182080-144N/A
3/31/20182133-89N/A
12/31/20172186-214N/A
9/30/20172106017N/A
6/30/20172026320N/A
3/31/20171976N/A12N/A
12/31/20161927N/A5N/A
9/30/20161917N/A16N/A
6/30/20161898N/A28N/A
3/31/20161848N/A31N/A
12/31/20151799N/A33N/A
9/30/20151757N/A29N/A
6/30/20151725N/A24N/A
3/31/20151694N/A18N/A
12/31/20141663N/A12N/A
9/30/20141642N/A11N/A
6/30/20141612N/A9N/A
3/31/20141633N/A13N/A
12/31/20131653N/A17N/A
6/30/20131716N/A18N/A
3/31/20131716N/A16N/A
12/31/20121716N/A14N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PCA's forecast earnings growth is above the savings rate (0.9%).

Earnings vs Market: Insufficient data to determine if PCA's earnings are forecast to grow faster than the French market

High Growth Earnings: Insufficient data to determine if PCA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if PCA's revenue is forecast to grow faster than the French market.

High Growth Revenue: Insufficient data to determine if PCA's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PCA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y